Skip to main content
Log in

Summary

This study examined the effect of nicotine on the expression of mutant p53 (mt-p53) in bladder cancer rats. The rat models of bladder cancer were established by infusing N-methyl-nitroso-urea (MNU, 10 mg/kg every 2 weeks for 8 weeks) into the bladder. Pathological examination on the bladder was conducted to confirm the establishment of the model. All the bladder cancer rats were randomly divided into an MNU group and 3 nicotine groups. In the nicotine groups, the rats were intragastrically administered nicotine at different concentrations (25, 15, 5 mg/kg respectively) 3 times per week for 8 weeks. The mt-p53 expression was detected by the immunohistochemical method. The results showed that rat bladder cancer models developed histopathological changes of bladder transitional cell carcinoma. The positive rate of mt-p53 expression in the 3 nicotine groups (25, 15, 5 mg/kg) was 75.00%, 58.33% and 41.67% by the 14th week, respectively, significantly higher than that in the MNU group (33.33%) (all P<0.05). The mt-p53 expression rate was positively correlated with the medication dose and time (P<0.05). It is concluded that nicotine may play an important role in the development of bladder cancer partially by increasing the expression of mt-p53.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wald NJ, Hackshaw AK. Cigarette smoking: an epidemiological overview. Br Med Bull, 1996, 52(1):3–11

    CAS  PubMed  Google Scholar 

  2. Gan J, Skipper PL, Gago Dominguez M, et al. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer. J Natl Cancer Inst, 2004,96(19):1425–1431

    Article  CAS  PubMed  Google Scholar 

  3. Qian LX, Liu XL, Ding H, et al. Dynamic observation on histopathological changes in bladder tumor induced by N-methyl-N-nitrosourea in rats. Chin J Exp Surg (Chinese), 2004,21(5):563–564

    Google Scholar 

  4. Chang FH, Liu SZ, Man D, et al. The determination of LD50 of nicotine and empyreumatic oil. Acta Acad Med Nei Mongol (Chinese), 1999, 21(3):190–191

    Google Scholar 

  5. Knowles MA. Tumor suppressor loci in bladder cancer. Front Biosci, 2007,12:2233–2251

    Article  CAS  PubMed  Google Scholar 

  6. Liu YH, Luo CL. Progress in research on p53 gene in bladder cancer. Zhong Guo Gong Ye Yi Xue Za Zhi (Chinese), 2003,16(1):37–40

    CAS  Google Scholar 

  7. Mitra AP, Datar RH, Cote RJ. Molecular staging of bladder cancer. BJU Int, 2005, 96(1):7–12

    Article  CAS  PubMed  Google Scholar 

  8. Gomez-Lazaro M, Fernandez-Gomez FJ, Jordan J. p53: twenty-five years understanding the mechanism of genome protection. J Physiol Biochem, 2004, 60(4):287–307

    Article  CAS  PubMed  Google Scholar 

  9. Algaba F, Trias I, Santinelli A, et al. TP53 in urologic tumors. Anal Quant Cytol Histol, 2003,25(3):123–130

    PubMed  Google Scholar 

  10. Yang CG, Zhang LJ, Li M, et al. Clinical significance of expression of p53 protein and apoptosis in bladder cancer. Practical J Cancer, 2007,22(1):34–36

    CAS  Google Scholar 

  11. Syrigos KN, Karapanagiotou E, Harrington KJ. The clinical significance of molecular markers to bladder cancer. Hybrid Hybridomics, 2004,23(6):335–342

    Article  CAS  PubMed  Google Scholar 

  12. Moonen PM, van Balken Ory B, Kiemeney LA, et al. Prognostic value of p53 for high risk superficial bladder cancer with long-term followup. J Urol, 2007,177(1): 80–83

    Article  CAS  PubMed  Google Scholar 

  13. Smith ND, Rubenstein JN, Eggener SE, et al. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer. J Urol, 2003,169(4):1219–1228

    Article  CAS  PubMed  Google Scholar 

  14. LaRue H, Allard P, Simoneau M, et al. P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers. Carcinogenesis, 2000,21(1):101–106

    Article  CAS  PubMed  Google Scholar 

  15. Kelsey KT, Hirao T, Hirao S, et al. TP53 alterations and patterns of carcinogen exposure in a U. S. population-based study of bladder cancer. Int J Cancer, 2005,117(3):370–375

    Article  CAS  PubMed  Google Scholar 

  16. Jemal A, Cokkinides VE, Shafey O, et al. Lung cancer trends in young adults: an early indicator of progress in tobacco control (United States). Cancer Causes Control, 2003,14(6):579–585

    Article  PubMed  Google Scholar 

  17. Tsurutani J, Castillo SS, Brognard J, et al. Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis, 2005,26(7):1182–1195

    Article  CAS  PubMed  Google Scholar 

  18. Kirk GD, Merlo C, O’Driscoll P, et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis, 2007, 45(1):103–110

    Article  PubMed  Google Scholar 

  19. Murta-Nascimento C, Schmitz-Dräger BJ, Zeegers MP, et al. Epidemiology of urinary bladder cancer: from tumor development to patient’s death. World J Urol, 2007,25(3):285–295

    Article  PubMed  Google Scholar 

  20. Bjerregaard BK, Raaschou-Nielsen O, Sorensen M, et al. Tobacco smoke and bladder cancer-in the European prospective investigation into cancer and nutrition. Int J Cancer, 2006,119(10):2412–2416

    Article  CAS  PubMed  Google Scholar 

  21. Pitard A, Brennan P, Clavel J, et al. Cigar, pipe, and cigarette smoking and bladder cancer risk in European men. Cancer Causes Control, 2001,12(6):551–556

    Article  CAS  PubMed  Google Scholar 

  22. Samanic C, Kogevinas M, Dosemeci M, et al. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev, 2006,15(7):1348–1354

    Article  PubMed  Google Scholar 

  23. Van Hemelrijck MJ, Michaud DS, Connolly GN, et al. Tobacco use and bladder cancer patterns in three western European countries. J Public Health (Oxf), 2009,31(3): 335–344

    Article  Google Scholar 

  24. Fondrevelle ME, Kantelip B, Reiter RE, et al. The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status. Urol Oncol, 2009,27(3):268–276

    CAS  PubMed  Google Scholar 

  25. Shin VY, Wu WK, Ye YN, et al. Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2. Carcinogenesis, 2004, 25(12): 2487–2495

    Article  CAS  PubMed  Google Scholar 

  26. Chen RJ, Ho YS, Guo HR, et al. Rapid activation of Stat3 and ERK1/2 by nicotine modulates cell proliferation in human bladder cancer cells. Toxicol Sci, 2008,104(2): 283–293

    Article  CAS  PubMed  Google Scholar 

  27. Puliyappadamba VT, Cheriyan VT, Thulasidasan AK, et al. Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent. Mol Cancer, 2010,9:220

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Feng Pan  (潘 峰).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, D., Pan, F., Li, B. et al. Intervention of nicotine on MNU-induced bladder cancer in rats. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 31, 103–106 (2011). https://doi.org/10.1007/s11596-011-0159-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-011-0159-z

Key words

Navigation